Citadel Advisors’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$697K Buy
21,400
+12,000
+128% +$394K ﹤0.01% 8502
2025
Q4
$298K Buy
+9,400
New +$283K ﹤0.01% 10167
2025
Q2
Sell
-34,300
Closed -$228K 14980
2025
Q1
$228K Buy
34,300
+25,400
+285% +$237K ﹤0.01% 10191
2024
Q4
$98.2K Sell
8,900
-300
-3% -$3.69K ﹤0.01% 11510
2024
Q3
$113K Buy
9,200
+1,000
+12% +$14.2K ﹤0.01% 10957
2024
Q2
$111K Sell
8,200
-41,100
-83% -$555K ﹤0.01% 10769
2024
Q1
$666K Buy
49,300
+48,700
+8,117% +$295K ﹤0.01% 7770
2023
Q4
$3.16K Sell
600
-3,800
-86% -$16.2K ﹤0.01% 13624
2023
Q3
$17.3K Sell
4,400
-8,200
-65% -$53.9K ﹤0.01% 12736
2023
Q2
$134K Buy
12,600
+10,900
+641% +$116K ﹤0.01% 10499
2023
Q1
$14.2K Sell
1,700
-2,700
-61% -$24.4K ﹤0.01% 13324
2022
Q4
$40.6K Buy
+4,400
New +$45.8K ﹤0.01% 12398
2021
Q3
Sell
-14,300
Closed -$481K 14614
2021
Q2
$481K Buy
+14,300
New +$506K ﹤0.01% 10141
2021
Q1
Sell
-4,300
Closed -$266K 13694
2020
Q4
$266K Buy
+4,300
New +$197K ﹤0.01% 9271

Other funds holding STOK